Journal article
Cost-Effectiveness of Midazolam Versus Haloperidol Versus Olanzapine for the Management of Acute Agitation in the Accident and Emergency Department
VKC Yan, M Haendler, H Lau, X Li, KSJ Lao, SH Tsui, CYL Yap, MRJ Knapp, EW Chan
Value in Health | Published : 2022
Abstract
Objectives: A multicenter randomized clinical trial in Hong Kong Accident and Emergency (A&E) departments concluded that intramuscular (IM) olanzapine is noninferior to haloperidol and midazolam, in terms of efficacy and safety, for the management of acutely agitated patients in A&E setting. Determining their comparative cost-effectiveness will further provide an economic perspective to inform the choice of sedative in this setting. Methods: This analysis used data from a randomized clinical trial conducted in Hong Kong A&E departments between December 2014 and September 2019. A within-trial cost-effectiveness analysis comparing the 3 sedatives was conducted, from the A&E perspective and a w..
View full abstractGrants
Funding Acknowledgements
This work was supported by grant 789813 from Research Grants Council, Hong Kong.